In this webinar, Robert Lowrey and David Siderovski will discuss novel AI-driven drug discovery approaches targeting ...

Learn more about whether Charles River Laboratories International, Inc. or Danaher Corporation is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial ...

These assays continue to infill the shallow, northern portion of the S1 ‘Starter Pit' with shallow, higher-grade intersections, and indicate potential refinement to modelling where vertical zones of ...

First Assay Results Reported for the Trapper Zone Following Completion of the 2025 Phase of the Mineral Resource Estimate ...

Nevada Organic Phosphate Inc. (CSE: NOP) (“NOP” or the “Company”), a B.C. based leader in organic sedimentary phosphate ...

Blood-based Biomarker for Alzheimer’s Disease Market to reach US$ 554.2 Mn by 2035 at 14.3% CAGR, driven by demand for ...

(WBL), a leader in native, long-read sequencing and epigenomic analysis, today announced a co-marketing agreement with Agilent Technologies to support the adoption of its Direct Targeted Methylation ...

Detailed price information for Atha Energy Corp. (SASK-X) from The Globe and Mail including charting and trades.

2025 Highlights: Building Momentum in Exploration and Financing In 2025, Cascade Copper continued to advance its portfolio of projects across British Columbia and Ontario, securing funding, and ...

No treatment-related adverse toxicity was observed across completed GLP studies, with consistent systemic exposure following ...

"Blencowe’s first stage 7 assay confirms graphite mineralisation at Orom-Cross" was originally created and published by Mining Technology, a GlobalData owned brand.

Polyoxometalates are promising inorganic drugs with antiviral activity; however, they pose a risk to humans because of their ...